{
    "url_original": "https://www.wsj.com/articles/moderna-lululemon-amazon-stocks-that-defined-the-week-11648849941?mod=markets_featst_pos1",
    "url": "moderna-lululemon-amazon-stocks-that-defined-the-week-11648849941",
    "title": "Moderna, Lululemon, Amazon: Stocks That Defined the Week",
    "sub_head": "Here are seven major companies whose stocks moved on the weekâ€™s news",
    "category_1": "Markets",
    "category_2": "Stocks",
    "image_1_url": "https://images.wsj.net/im-517207?width=860&height=573",
    "image_1": "im-517207.jpg",
    "time": "2022-04-01 17:52:00",
    "body": "Moderna Inc.<br />A new booster-shot endorsement gave Moderna a shot in the arm. The Food and Drug Administration and the Centers for Disease Control and Prevention on Tuesday cleared extra shots from Moderna and from  Pfizer Inc.  and partner  BioNTech SE  for people 50 years and older. Those adults can now get the shots at least four months after a first booster dose. Moderna shares rose 4.4% Tuesday."
}